ABBOTT LABORATORIES — Director's Dealing 2010

Apr 21, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FACET BIOTECH CORP (FACT)
CIK: 0001441848
Period of Report: 2010-04-20

Reporting Person: ABBOTT LABORATORIES (10% Owner)
Reporting Person: Amber Acquisition Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19257669	Direct

Footnotes

F1: This form is a joint filing by Abbott Laboratories ("Abbott") and Amber Acquisition Inc., a wholly-owned subsidiary of Abbott (the "Purchaser").

F2: This Form 3 relates to shares of common stock, par value $0.01 per share (the "Common Stock"), and the associated preferred stock purchase rights issued in connection with the Rights Agreement, dated as of September 7, 2009, as amended by the amendments thereto dated as of December 15, 2009, December 16, 2009 and March 9, 2010, by and between Facet and Mellon Investor Services LLC (together with the Common Stock, the "Shares"), of Facet.

F3: Reflects Shares of Facet purchased upon the expiration of a tender offer commenced pursuant to the Tender Offer Statement on Schedule TO, as amended or supplemented, initially filed with the Securities and Exchange Commission on March 23, 2010 by Abbott and the Purchaser. Amount includes 914,673 shares tendered through guaranteed delivery procedures.